OxyPrem 1.4
Tissue Oximetry System
Newborn Brain Protection
Reusable 8-Wavelength Cerebral Oximeter
OxyPrem 1.4 uses harmless light (NIRS) to determine absolute haemoglobin oxygen saturation in human tissue.
Non-invasive
OxyPrem 1.4 offers a two-year sensor lifetime and high component quality, while substantially reducing waste.
Reusable
With its excellent performance in repeated placement and its high reading certainty, OxyPrem 1.4 achieves new levels in precision.
Precise
High component quality and advanced algorithms provide consistent readings, also across varying perfusion environments.
Perfusion independent
Due to OxyPrem 1.4's glue-free fixation, skin damage from adhesives is avoided. Its very soft silicone hull is made for comfortable wear.
Comfortable
OxyPrem 1.4 can be used in any patient at risk of hypoxia and on any body part which is at least 30 mm thick.
Versatile
Since OxyPrem 1.4 is reusable, costs are reduced drastically when used routinely or over longer time periods.
Cost efficient
Testimonials
What clinicians say about us and OxyPrem 1.4
Director of Neonatal Intensive Care,
Greek NICU
“…this piece of instrument will add significantly to the care of sick neonates.”
Head of the NICU
Swiss NICU
“OxyPrem AG shapes their products with great determination towards the real needs and harsh realities of neonatal intensive care units.”
Owner and CEO,
international medical device distribution
company
“The great benefit behind the OxyPrem probe is its reusable design.”
Associate Professor
Indian NICU
“…optimistic that this device will improve the care of neonates in the future.”
Chief Neonatologist
Spanish NICU
“…monitor is simple to use and gives easily to interpret information.”
Deputy Head Department of Neonatology
Polish NICU
“…What makes the sensor unique is that it is designed for multiple use.”
Deputy Head Division of Neonatology
Austrian NICU
“…high precision is of high importance for any future clinical application.“
Head of the NICU
Belgian NICU
“…certainly superior to the current systems on the market.”
The European Commission
“…has been developed just around the needs of the end users, taking into account the clinical and medical needs, and that the targeted market is vastly underserved…”
Watch the OxyPrem 1.4 intro video
Publications
Quantifying the effect of adipose tissue in muscle
We measured StO2 of a liquid phantom by 3 continuous wave (CW) oximeters (Sensmart Model X-100 Universal Oximetry System, INVOS 5100C, and OxyPrem v1.3), as well as a frequency-domain oximeter, OxiplexTS, through superficial layers with 4 different thicknesses
